Investor Slams 'Hostile' Allergan Actions, Urges Deal Talks
A hedge fund with a stake in Allergan Inc. blasted the Botox maker for spurning negotiations over a $53 billion offer from Valeant Pharmaceuticals International Inc., saying late on Thursday the...To view the full article, register now.
Already a subscriber? Click here to view full article